Among the S100 proteins (S100A2, S100A7, and S100A11) examined in the present study, S100A11 levels were significantly higher in adenocarcinomas with KRAS mutations and strong proliferating activity (Fig 3). Here, S100A11 is linked to adenocarcinoma.